David et al., 1968 - Google Patents
A virilizing adrenal tumor with borderline elevation of urinary 17-ketosteroidsDavid et al., 1968
- Document ID
- 25140298030965039
- Author
- David R
- August G
- Gandy H
- Publication year
- Publication venue
- Pediatrics
External Links
Snippet
In vivo and in vitro studies on a 6-year-old boy with a virilizing adrenal adenoma are reported. Of particular interest was the modest elevation of urinary 17-ketosteroids. The awareness of this observation is emphasized. The main biochemical findings were: elevated …
- 230000002485 urinary 0 title abstract description 40
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Peterson | Adrenocortical steroid metabolism and adrenal cortical function in liver disease | |
| SCHNEIDER et al. | Increased estrogen production in obese men | |
| Peterson et al. | The physiological disposition and metabolic fate of hydrocortisone in man | |
| Hey et al. | OESTRADIOL-17β AND TESTOSTERONE IN RAT TESTIS TISSUE: EFFECT OF GONADO-TROPHINS, LOCALIZATION AND PRODUCTION IN VITRO | |
| FRENCH et al. | Testicular feminization: clinical, morphological and biochemical studies | |
| Abdel-Aziz et al. | Metabolism of radioactive 17α-ethynylestradiol by women | |
| HENDRIKX et al. | Influence of a low-calorie diet and fasting on the metabolism of dehydroepiandrosterone sulfate in adult obese subjects | |
| Gold et al. | Quantitative Determination of the Urinary Cortisolc Metabolites,“Tetrahydro F,”“Allo-Tetrahydro F” and “Tetrahydro E”: Effects of Adrenocorticotropin and Complex Trauma in the Human | |
| Dohan et al. | Hormone excretion in liver disease | |
| Vermeulen | The metabolism of 4-14C prednisolone | |
| Burstein et al. | Biosynthesis of C19 steroids from 4-14C-cholesterol and 7-3H-pregnenolone in vivo: consideration of new pathways | |
| David et al. | A virilizing adrenal tumor with borderline elevation of urinary 17-ketosteroids | |
| BURTON et al. | The conversion of cortisone acetate to other alpha-ketolic steroids | |
| Cohn et al. | Androgen release and synthesis in vitro by human adult adrenal glands | |
| SLAUNWHITE JR et al. | Metabolism of 4-C14-testosterone in human subjects III. Fate of androsterone and etiocholanolone | |
| Finkelstein | Adrenocortical heterofunction | |
| Sjöberg et al. | Circadian variation in systemic hormone levels in healthy men | |
| Fishman et al. | Further studies of the metabolism of oestradiol in man | |
| Gray et al. | Steroid studies in normal and adipose children | |
| Dorfman | Steroid hormone metabolism | |
| BAULIEU et al. | Metabolic observations in a case of pure primary hyperaldosteronism | |
| ROBERTS et al. | 17α-hydroxypregnenolone as a precursor of urinary steroids in a patient with a virilizing adenoma of the adrenal | |
| GOLD | Blood corticoids: Their Measurement and significance—a review | |
| Gray et al. | The metabolism of [4-14C] cortisol in patients with collagen diseases | |
| Jänne et al. | Plasma pregnenolone, progesterone, 17‐hydroxyprogesterone, testosterone and 5α‐dihydrotestosterone in different types of congenital adrenal hyperplasia |